Yuki Gosei Kogyo Past Earnings Performance
Past criteria checks 5/6
Yuki Gosei Kogyo has been growing earnings at an average annual rate of 36.3%, while the Chemicals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 5.4% per year. Yuki Gosei Kogyo's return on equity is 5.4%, and it has net margins of 5%.
Key information
36.3%
Earnings growth rate
36.3%
EPS growth rate
| Chemicals Industry Growth | 6.6% |
| Revenue growth rate | 5.4% |
| Return on equity | 5.4% |
| Net Margin | 5.0% |
| Next Earnings Update | 15 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Yuki Gosei Kogyo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 12,751 | 634 | 1,446 | 612 |
| 30 Sep 23 | 12,336 | 338 | 1,438 | 553 |
| 30 Jun 23 | 12,607 | 474 | 1,498 | 575 |
| 31 Mar 23 | 12,839 | 556 | 1,503 | 589 |
| 31 Dec 22 | 13,007 | 310 | 1,574 | 650 |
| 30 Sep 22 | 13,456 | 550 | 1,598 | 653 |
| 30 Jun 22 | 12,965 | 525 | 1,557 | 448 |
| 31 Mar 22 | 12,361 | 248 | 1,524 | 377 |
| 31 Dec 21 | 12,047 | 432 | 1,470 | 228 |
| 30 Sep 21 | 10,864 | 187 | 1,405 | 204 |
| 30 Jun 21 | 11,069 | 345 | 1,386 | 198 |
| 31 Mar 21 | 11,091 | 288 | 1,360 | 211 |
| 31 Dec 20 | 10,117 | -56 | 1,338 | 343 |
| 30 Sep 20 | 10,831 | 86 | 1,353 | 337 |
| 30 Jun 20 | 10,723 | -87 | 1,341 | 434 |
| 31 Mar 20 | 10,717 | -42 | 1,332 | 629 |
| 31 Dec 19 | 11,125 | 141 | 1,354 | 549 |
| 30 Sep 19 | 10,887 | 200 | 1,320 | 530 |
| 30 Jun 19 | 10,620 | 208 | 1,343 | 466 |
| 31 Mar 19 | 10,272 | 104 | 1,357 | 345 |
| 31 Dec 18 | 9,808 | 115 | 1,327 | 311 |
| 30 Sep 18 | 9,705 | 5 | 1,349 | 363 |
| 30 Jun 18 | 9,806 | 19 | 1,343 | 399 |
| 31 Mar 18 | 10,073 | 125 | 1,371 | 338 |
| 31 Dec 17 | 10,345 | 196 | 1,415 | 321 |
| 30 Sep 17 | 10,603 | 322 | 1,431 | 304 |
| 30 Jun 17 | 10,523 | 381 | 1,410 | 270 |
| 31 Mar 17 | 10,396 | 355 | 1,384 | 404 |
| 31 Dec 16 | 10,125 | 326 | 1,373 | 446 |
| 30 Sep 16 | 10,034 | 302 | 1,369 | 456 |
| 30 Jun 16 | 10,394 | 239 | 1,379 | 541 |
| 31 Mar 16 | 10,576 | 350 | 1,362 | 407 |
| 31 Dec 15 | 10,315 | 362 | 1,332 | 345 |
| 30 Sep 15 | 10,439 | 454 | 1,302 | 369 |
| 30 Jun 15 | 10,207 | 461 | 1,300 | 292 |
| 31 Mar 15 | 10,005 | 330 | 1,319 | 276 |
| 31 Dec 14 | 10,095 | -17 | 1,318 | 280 |
| 30 Sep 14 | 9,808 | -210 | 1,312 | 283 |
| 30 Jun 14 | 9,480 | -235 | 1,299 | 321 |
| 31 Mar 14 | 9,422 | 53 | 1,289 | 360 |
| 31 Dec 13 | 9,662 | 37 | 1,278 | 367 |
| 30 Sep 13 | 9,457 | 75 | 1,267 | 280 |
| 30 Jun 13 | 9,099 | 442 | 1,194 | 269 |
Quality Earnings: 4531 has high quality earnings.
Growing Profit Margin: 4531's current net profit margins (5%) are higher than last year (2.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4531's earnings have grown significantly by 36.3% per year over the past 5 years.
Accelerating Growth: 4531's earnings growth over the past year (104.5%) exceeds its 5-year average (36.3% per year).
Earnings vs Industry: 4531 earnings growth over the past year (104.5%) exceeded the Chemicals industry -6.6%.
Return on Equity
High ROE: 4531's Return on Equity (5.4%) is considered low.